US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Compounded Plaquex

Reason Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.

AnazaoHealth Corporation D0384-2015
Class II · Moderate risk Terminated

KETOROLAC Tromethamine Inj.

Reason Crystallization

Hospira Inc. NDC 0409-3796-01 D-0483-2015
Class II · Moderate risk Terminated

KETOROLAC Tromethamine Inj.

Reason Crystallization

Hospira Inc. NDC 0409-3795-01 D-0482-2015
Class II · Moderate risk Terminated

Ketorolac Tromethamine Ophthalmic Solution

Reason Presence of Particulate Matter: lot is not meeting the specification limit for number of particles present in the solution.

Sun Pharma Global Fze NDC 41616-219-90 D-0394-2015
Class II · Moderate risk Terminated

Levetiracetam

Reason Failed Dissolution Specifications: 6 month time point.

Sun Pharma Global Fze D-0386-2015
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: One lot exceeded the mechanical peel specification

Noven Pharmaceuticals, Inc. NDC 68968-5555-3 D-1086-2015
Class II · Moderate risk Terminated

Benzonatate Capsules

Reason Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules

American Health Packaging NDC 68084-214-01 D-0430-2015
Class II · Moderate risk Terminated

Glycopyrrolate injection

Reason Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" and "3" making the actual "Use By 3/2015" date appear to read "Use By8/2015".

SCA Pharmaceuticals D-0339-2015
Class II · Moderate risk Terminated

Virazole

Reason Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.

Valeant Pharmaceuticals North America LLC NDC 0187-0007-14 D-0379-2015
Class II · Moderate risk Terminated

Children's Loratadine Syrup

Reason Presence of Foreign Substance: Presence of blue plastic floating in loratadine syrup.

Taro Pharmaceuticals U.S.A., Inc. D-0383-2015
Class II · Moderate risk Terminated

L-cysteine various strengths

Reason Lack of sterility assurance.

Walgreens Infusion Services D-0374-2015
Class II · Moderate risk Terminated

Diphenhydramine 50 mg/ml vials

Reason Lack of sterility assurance.

Walgreens Infusion Services D-0372-2015
Class II · Moderate risk Terminated

Dehydrated alcohol vials

Reason Lack of sterility assurance.

Walgreens Infusion Services D-0371-2015
Class II · Moderate risk Terminated

Thiamine 100 mg/ ml vials

Reason Lack of sterility assurance.

Walgreens Infusion Services D-0367-2015